After validating the functionality of the scFv RB4 fragment (affinity, specificity and recognition of ETB+ melanoma cell lines), it was inserted into a second-generation CAR structure with a CD8 hinge and CD28 and CD3z as stimulation domains (Supplementary Fig. 1). Here, CD28 is linked to melanoma.